EGFR and glioblastoma: By focusing on GBM whole exome sequencing data in 90 Korean patients, Harim et al.21 have identified greater enrichment of the P53 pathway with respect to that in TCGA cohort (n = 250), although EGFR amplification was not described (Table 2).